» Articles » PMID: 35685203

Gender Differences in the Attitudes and Management of People with Obesity in Saudi Arabia: Data from the ACTION-IO Study

Overview
Publisher Dove Medical Press
Specialty Public Health
Date 2022 Jun 10
PMID 35685203
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Several studies have investigated gender differences in various obesity-related outcomes. Females were found to have more accurate weight perception and reported more frequency of attempted weight loss. The objective of this study was to assess gender differences in the attitudes and management of people with obesity (PwO) in Saudi Arabia using data from the ACTION-IO study.

Patients And Methods: A survey was conducted in Saudi Arabia in June and July 2018 on adults with obesity (based on self-reported body mass index of ≥30 kg/m).

Results: A total of 1000 people with obesity completed the survey; 565 (56.5%) were male (mean age of 36.9 years and mean BMI of 33.5 kg/m) and 435 (43.5%) were female (mean age of 36.3 years and mean BMI of 34.5 kg/m). The two most reported motivations for wanting to lose weight for both groups were to improve appearance (38%) and to have more energy (35%). Females were more likely to trust their health-care provider (HCP) advice about weight management when compared to males (87% females, 82% males, p = 0.059) and were more likely to have concerns regarding long-term safety associated with prescription weight loss medications (65% female versus 59% males, p = 0.043). On the other hand, males were more likely to seek their physician to prescribe weight loss medication if they hear of a new medication (55% males versus 46% females, p = 0.014), and more to believe that there are good options available for weight loss medications (74% males versus 67% females, p = 0.040). Also, more males prefer to take weight loss medications than to have a weight loss surgery (65% males, 59% females, p = 0.054).

Conclusion: Overall, this study increases our understanding on the attitudes of both females and males towards the management of weight loss and opens the discussion for gender-specific weight loss interventions.

Citing Articles

Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia.

Butt M, Alkhalifah K, Riazuddin M, Almuammar S, Almuammar S, Alhifthi G Ann Saudi Med. 2024; 44(6):361-368.

PMID: 39651921 PMC: 11627033. DOI: 10.5144/0256-4947.2024.361.


Knowledge, attitudes, and practices towards the use of GLP-1 receptor agonists for weight loss among the general population in Jordan; A cross-sectional study.

Abutaima R, Barakat M, Sawan H, Al Omari S, Mhaidat N PLoS One. 2024; 19(12):e0314407.

PMID: 39636914 PMC: 11620468. DOI: 10.1371/journal.pone.0314407.


Assessment of Binge Eating Behavior, Body Shape Concerns, and Associated Factors among Female Adolescents of Northern Saudi Arabia: A Cross-Sectional Study.

Alhuwaydi A, Alqahtani A, Alsadun R, Alruwaili O, Thirunavukkarasu A, Abdel-Salam D Nutrients. 2024; 16(18).

PMID: 39339682 PMC: 11435104. DOI: 10.3390/nu16183082.


Prevalence and Awareness of Obesity and Bariatric Surgeries in the Northern Borders Region, Saudi Arabia.

Alanazi R, Hussain M, Alanazi R, Alanazi S, Alanazi R, Fawzy M Cureus. 2024; 15(12):e50261.

PMID: 38196425 PMC: 10775188. DOI: 10.7759/cureus.50261.


Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.

Al Jadani J, Albadr N, Alshammari G, Almasri S, Alfayez F, Yahya M Nutrients. 2023; 15(22).

PMID: 38004149 PMC: 10675668. DOI: 10.3390/nu15224755.


References
1.
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T . Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity (Silver Spring). 2020; 28(9):1606-1612. PMC: 7283831. DOI: 10.1002/oby.22923. View

2.
Garg S, Kim L, Whitaker M, OHalloran A, Cummings C, Holstein R . Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):458-464. PMC: 7755063. DOI: 10.15585/mmwr.mm6915e3. View

3.
Dietz W, Baur L, Hall K, Puhl R, Taveras E, Uauy R . Management of obesity: improvement of health-care training and systems for prevention and care. Lancet. 2015; 385(9986):2521-33. DOI: 10.1016/S0140-6736(14)61748-7. View

4.
Afshin A, Forouzanfar M, Reitsma M, Sur P, Estep K, Lee A . Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017; 377(1):13-27. PMC: 5477817. DOI: 10.1056/NEJMoa1614362. View

5.
Kjellberg J, Larsen A, Ibsen R, Hojgaard B . The Socioeconomic Burden of Obesity. Obes Facts. 2017; 10(5):493-502. PMC: 5741162. DOI: 10.1159/000480404. View